06 Oct 2016
DMI Seminar - Matthias Groeschel & Till Omansen
13 Oct 2016
12.00 - 1.00PM
Visiting MD/PhD candidates, Matthias Groeschel MD and Till Omansen MD from the University of Groningen in Holland, will speak to Recombinant BCGs: Leveraging heterologous ESX-1 mediated cytosolic access for improved anti-tuberculosis vaccine design and Mycobacterium ulcerans chemotherapy in the mouse model: optimizing old drugs for new regimens. For all enquiries, please contact Stephan Kaiser.